Cargando…

Hidradenitis suppurativa flares following COVID-19 vaccination: A case series

Detalles Bibliográficos
Autores principales:	Martora, Fabrizio, Picone, Vincenzo, Fabbrocini, Gabriella, Marasca, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916983/ https://www.ncbi.nlm.nih.gov/pubmed/35308064 http://dx.doi.org/10.1016/j.jdcr.2022.03.008

Ejemplares similares

Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review
por: Ruggiero, Angelo, et al.
Publicado: (2022)

How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis
por: Martora, Fabrizio, et al.
Publicado: (2023)

Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?
por: Ruggiero, Angelo, et al.
Publicado: (2022)

A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa
por: Marasca, Claudio, et al.
Publicado: (2018)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
por: Martora, Fabrizio, et al.
Publicado: (2023)

Secukinumab and hidradenitis suppurativa: Friends or foes?
por: Marasca, Claudio, et al.
Publicado: (2019)

Hair removal and deodorants in hidradenitis suppurativa: An online survey on patients' habits
por: Lauro, Wanda, et al.
Publicado: (2022)

Herpes zoster and alopecia areata following mRNA BNT162b2 COVID‐19 vaccine: Controversial immune effects
por: Martora, Fabrizio, et al.
Publicado: (2022)

Pityriasis rosea after Moderna mRNA‐1273 vaccine: A case series
por: Martora, Fabrizio, et al.
Publicado: (2021)

A Case of New-Onset Lichen Planus after COVID-19 Vaccination
por: Picone, Vincenzo, et al.
Publicado: (2022)

Response to Martora et al’s “Hidradenitis suppurativa flares following COVID-19 vaccination: a case series”
por: Alexander, Helen, et al.
Publicado: (2022)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

Characterizing perimenstrual flares of hidradenitis suppurativa
por: Collier, Erin K., et al.
Publicado: (2020)

Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511”
por: Potestio, Luca, et al.
Publicado: (2022)

“Covid arm”: Abnormal side effect after Moderna COVID‐19 vaccine
por: Picone, Vincenzo, et al.
Publicado: (2021)

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature
por: Martora, Fabrizio, et al.
Publicado: (2022)

Hydroxychloroquine for the treatment of hidradenitis suppurativa
por: Brant, Elena Gonzalez, et al.
Publicado: (2023)

Multidisciplinary Management of Adolescents with Hidradenitis Suppurativa – Series of Cases and Literature Review
por: Țarcă, Elena, et al.
Publicado: (2021)

Onset of vitiligo in a psoriasis patient on ixekizumab
por: Marasca, Claudio, et al.
Publicado: (2021)

Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report
por: Ruggiero, Angelo, et al.
Publicado: (2023)

Intermittent low-dose corticosteroid therapy for hidradenitis suppurativa: A case series
por: Erlendsson, Andrés M., et al.
Publicado: (2021)

A case of herpes zoster ophthalmicus after third dose of Comirnaty (BNT162b2 mRNA) vaccine
por: Martora, Fabrizio, et al.
Publicado: (2022)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

Erythrasma in 4 skin of color patients with hidradenitis suppurativa
por: Gruenstein, Diana, et al.
Publicado: (2021)

Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A series of 16 cases
por: Masson, Rahul, et al.
Publicado: (2023)

Impact of COVID‐19 pandemic and the use of telemedicine on the diagnosis and treatment of tinea corporis: An experience of Southern Italy center
por: Picone, Vincenzo, et al.
Publicado: (2022)

Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
por: Martora, Fabrizio, et al.
Publicado: (2023)

Role of Nutrition and Adherence to the Mediterranean Diet in the Multidisciplinary Approach of Hidradenitis Suppurativa: Evaluation of Nutritional Status and Its Association with Severity of Disease
por: Barrea, Luigi, et al.
Publicado: (2018)

Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
por: Napolitano, Maddalena, et al.
Publicado: (2017)

Effects of mixed-technology CO(2) and Ga-As laser in patients with hidradenitis suppurativa–A case series
por: Lindén, Olof, et al.
Publicado: (2022)

Association of hidradenitis suppurativa and keloid formation: A therapeutic challenge
por: Jfri, Abdulhadi, et al.
Publicado: (2019)

Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients
por: Fabbrocini, Gabriella, et al.
Publicado: (2018)

Hidradenitis suppurativa in acute myeloid leukemia: Review of disease course and management
por: Chen, Stella X., et al.
Publicado: (2021)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study
por: Burlando, Martina, et al.
Publicado: (2022)

“PiMa sign”: A possible correlation between dermographism and pityriasis versicolor?
por: Martora, Fabrizio, et al.
Publicado: (2022)

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020)

Metabolic endoscopy and a simplified low-carbohydrate–high-dietary fiber template as novel treatments for hidradenitis suppurativa – A case series
por: Mandour, Mandour O., et al.
Publicado: (2023)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
por: Martora, Fabrizio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0mfrmikb0rk3pujm27aj4gth88